"Join the authors of the recent JASIST opinion paper ... 'Global health crises are also information crises: A call to action' to discuss the role that information scientists should play in addressing the current crisis and preparing for future crises.
In the paper, the authors recommend the formation of 'special interest groups within professional associations; specifically, using this paper as a platform, information scientists should meet to develop a “formal” shared research, training, policy, implementation agenda centered around the application of information science to global health crises and then meet with global health (clinical, research, and policy) colleagues to share and refine this agenda and make it the most relevant and impactful.'
This webinar and discussion will serve as the first step in moving this action item forward."Find out more »
"A lack of time to engage with patients in the diagnostic process is a major concern of health care professionals. The major challenge is that these professionals are inundated with data; upwards of 930 pieces of chemistry and hematology data are reviewed by primary care physicians each week!₁ The complexity of healthcare decision making coupled with an increased volume of available information, may lead to variability in quality and cost of care. While quality results have been the primary focus of the laboratory, many misdiagnoses and treatment errors can be attributed to errors during the selection and interpretation of test results. Lab tests play a key role in clinical decision making, and correct interpretation is critical. In a survey, 75% of clinicians want more interpretation of lab results₂
Ultimately, making a holistic, patient-centric decision is a matter of bringing together the right information at the right time to treat the right person. To alleviate this complexity and avoid errors, many health systems deploy some form of clinical decision support (CDS) technology. Join Abbott, with Jeremy Schubert and Dr. Chad Malone, to learn about how the AlinIQ Clinical Insights solution can help drive clinical practice towards proper standards of care while integrating seamlessly into existing clinical workflows. AlinIQ Clinical Insights will provide the best outcome for patients within key disease areas, such as diabetes and heart failure."
Note: This is part three of a four-part webinar series.Find out more »
"The internet of things is changing our lives, touching many essential parts —from the “smart” mobile phones we use to the servers where all our pictures are stored. Changes driven by and derived from IoT are also occurring in the R&D lab. At its simplest, IoT applied to the Lab, or Internet of Lab Things (IoLT), refers to lab devices that communicate virtually and without constant human intervention. In this webinar, learn how this technology is being used to capture lab-wide contextual data to reduce errors, improve instrument performance and return more time back to scientists."Find out more »
"The purpose of this webinar is to educate our audience on ways in which you can use technology to improve patient safety and care.
Learning Objectives - After participating in this activity, the learner should be better able to:
* Identify new and varying approaches to completing advanced clinical workflows on a single mobile device
* Describe methods used to improve communication across the entire care team
* Define strategic imperatives towards change management among clinical staff when deploying a new clinical communication and collaboration solution across the organization
* Define benefits of migrating traditional physical hardware onto a new cloud platform"
"The capabilities of liquid chromatography coupled to mass spectrometry make the technology a very attractive tool in clinical laboratory settings. However, not all laboratorians have a basic understanding of clinical mass spectrometry. In this presentation, the fundamentals of liquid chromatography and mass spectrometry will be briefly discussed. Further, a liquid chromatography-mass spectrometry assay validation will be reviewed.
1. List the basic components of a liquid chromatograph and mass spectrometer.
2. Recognize the benefits of liquid chromatography-mass spectrometry to the clinical laboratory."
"Mass spectrometry-based proteomics allows the simultaneous measurement of a large number of proteins and has been widely used for protein biomarker discovery and validation. Quantitative proteomics techniques were primarily developed with small sample numbers, but research involving clinical cohorts requires robust quantitation over a large number of samples. To ensure data accuracy, additional technical and analytical quality control measures need to be implemented in proteomics research involving clinical research cohorts. This webinar will discuss the key considerations and suggest some strategies that has proved useful in clinical research study design."Find out more »
Benchling for Lab Automation is how biotechs like Regeneron and Recursion Pharmaceuticals orchestrate their instruments, automatically feed results into their informatics systems, and save 10 hours per run — no inefficient busywork necessary.
In this webinar, we'll give you a firsthand look at how Benchling for Lab Automation can help you increase experimental scale, enhance R&D productivity, improve data integrity, and derive deeper experimental insights.
"Exponential growth in the number of chemistry publications produced each year has made sorting through research topics increasingly difficult. This growth does have the advantage of exposing some of the flaws in the publication process that future chemists might be able to improve. Issues such as lack of reproducibility, overemphasis on citation metrics, data falsification, and predatory journals will have to be addressed by the next generation of scientists. To that end a new type of chemical literature course in the undergraduate and graduate curricula at Vanderbilt University is being introduced. This course will be divided into three sections.
The first half will focus on information seeking and literacy by covering contentious topics within chemistry (e.g., fracking, nuclear energy, thalidomide, and research related to the supposed vaccine/autism link) and teaching students about the databases and techniques that can help them identify trustworthy information.
The second portion will focus on the history, present, and future of scholarly publishing. Students will learn about current practices by hearing from a journal editor and an acquisition librarian that frequently negotiates with publishers.
The final portion will be on data management as a potential solution to some of the issues with publishing. Students will learn how to manage, find, store, and share data related to their research. Other scientific literature or information curricula will be compared to this course by distributing a survey to faculty and staff at colleges and universities and student learning will be assessed by using a pre/post test to determine their confidence and comfort with finding, describing, publishing, and sharing research articles and data."Find out more »
"After building a model and validating it in an external dataset, it’s time to put it into practice. What is the best way to use it? Should it notify physicians as soon as the inferences are done? Should it notify radiologists? Or is a worklist prioritization the best way to use the model outputs? In the case of automated segmentation, we can also send back results to be viewed in the PACS. Should this result be instantaneously available for every study, or, should the radiologist request these results for specific cases? There is likely not a correct answer that is best in all cases, but there are definitely better options for each kind of model."Find out more »
"Eurofins TestAmerica is offering this 4 Part Webinar Series to review the basic tenants for a project team to interface and communicate with an environmental testing laboratory to execute a successful sampling project. These webinars are offered as an additional tool to support individuals who may be starting their career in the environmental field and will be interfacing with an environmental testing laboratory. These webinars are also appropriate for the seasoned professional who may be looking for a refresher in this area. This 4 Part Webinar Series can be viewed individually or as a series."
Part 3: What you will learn:
* Who writes and published analytical methods and where can I find them?
* What items should be considered during the method selection process?
* When and what should I communicate to the lab?
* What methods are available and what are the differences?
* What information is documented in the case narrative?
* What is the final deliverable?
"Analytical quality control refers to all those processes and procedures designed to ensure that the results of laboratory analysis are consistent, comparable, accurate and within specified limits. Quality control begins with sample collection and ends with the reporting of data. It is achieved through laboratory control of analytical performance.
This presentation will discuss Analytical Quality Control for pharmaceuticals as it relates to pipetting, weighing, sample collection and preparation, as well as analytical method and equipment qualification.
We will examine best practices to provide thoughts and ideas to develop or improve the performance of your current system. This presentation will help attendees understand the instrument qualification and system validation process and will provide instruction on how to prepare for audits and how to become FDA compliant."Find out more »
"Widespread adoption of the EHR has led to a proliferation of the quantity of digitized health care data, but these data have not always translated into improved data quality. Despite increasing interest in using “real-world data” to power clinical research, most clinical trials and research protocols still rely on time-intensive, manual data entry. The power of the EHR remains largely untapped in clinical research. In this webinar, Dr. Ann Marie Navar and Dr. Eric Peterson, researchers at the Duke Clinical Research Institute and strategic advisors to Cerner Corp., will present an overview of their research using EHR data from multiple, connected health systems. They will also present their work with Cerner to build an EHR-enabled network to streamline clinical research conducted across multiple institutions, the Learning Health Network."
NOTE: Free for AMIA members and non-membersFind out more »
"Cell and tissue culture are necessary for modeling human disease, but they come with many challenges. These techniques are often time-consuming and contamination, pipetting accuracy, and environmental variability can all impact your experimental results. Choosing the right tools—incubators, biological safety cabinets, and pipetting instruments—can help you overcome these challenges. Join Lab Manager and our panel of experts as we discuss some of the latest technology for cell and tissue culture and how they’re changing the way human disease is modeled."Find out more »
"This is the first Webinar in a series on Metals Analysis. We will discuss the historical development of analytical techniques for metals analysis in environmental chemistry, including flame atomic adsorption (AA), graphite furnace AA, inductively coupled plasma (ICP) with optical emission spectroscopy, and ICP mass spectrometry(ICPMS). Techniques and methods typically used today for routine metals analysis will be presented. Pros and cons of the instrumental techniques will be discussed, along with basic principles and typical performance criteria. Limitations of routine methods and techniques for overcoming them will be presented in subsequent Webinars.
Topics The Presentation Will Cover Include:
* General Overview of analytical techniques for metals analysis
* Pros and Cons of instrumental techniques
* Routine ICP-OES and ICPMS techniques – strengths and weaknesses
* Review of EPA methods (SW-846 Methods & EPA Office of Water Methods)"
"Analysts touted 2018 as the “Year of Blockchain in Healthcare”. It’s 2020 and that didn’t really happen. Starting with the Department of Health and Human Services’ “Blockchain Challenge” in 2016, there was a deluge of potential scenarios and solutions but the industry struggled to prove and implement the value of Distributed Ledger Technology (DLT)/Blockchain at scale. Fast forward to 2020 where we are facing increasing costs and the need for new therapies in the healthcare and life sciences supply chain. We now have more mature business value driven solutions with more mature technology. We have a better understanding of where real value exists that will not only reduce costs but enable care transformation and improved outcomes with accelerated drug development timelines.
In this webinar we’ll explore what’s different now and what the combination of new healthcare and life sciences needs and solutions can look like in 2020 and beyond leveraging DLT/Blockchain."Find out more »